Eurofins BioPharma Product Testing opens new site in China

Xin Yi, 易芯,Marketing Supervisor, Eurofins BioPharma Product Testing Shanghai, xin.yi@cpt.eurofinscn.com

Eurofins BioPharma Product Testing is delighted to announce its first laboratory facility opening in Shanghai in March 2023, (Eurofins BPT Shanghai). The Eurofins BPT Shanghai site has been under construction since 2021 and covers an area of approximately 2000 m². The laboratory construction was completed with the support of Eurofins’ European and US laboratories, using a globally harmonised LIMS, which meets the requirements of GMP regulations in China, the US and Europe. As the 40th GMP laboratory in the global Eurofins laboratory network, the Eurofins BPT Shanghai facility can provide safety testing services under GMP conditions for drugs and medical devices. Eurofins BPT Shanghai laboratory testing capabilities include: • Cell Banking and Storage Service in a GMP Environment • Cell/Virus Bank Characterisation • Viral Clearance Validation • Microbiological Testing • Physical-Chemical Analysis • Customised Method Development and Validation

Eurofins BPT Shanghai has well-trained experienced scientists who are experts on regulations spanning China, US, Europe and Japan. The team can also develop quick and stable testing methods based on global experience and client requirements. This ensures each product’s quality and safety and enables Chinese pharma customers to accelerate the process of product commercialisation overseas. For more information, visit: www.eurofins.cn/shanghai/